- Home
- CCEL vs TPCS Comparison
CCEL vs TPCS Comparison
Compare CCEL & TPCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCEL
- TPCS
- Stock Information
- Founded
- CCEL 1989
- TPCS 1956
- Country
- CCEL United States
- TPCS United States
- Employees
- CCEL N/A
- TPCS N/A
- Industry
- CCEL Managed Health Care
- TPCS Metal Fabrications
- Sector
- CCEL Health Care
- TPCS Industrials
- Exchange
- CCEL Nasdaq
- TPCS Nasdaq
- Market Cap
- CCEL 39.9M
- TPCS 42.6M
- IPO Year
- CCEL 1997
- TPCS N/A
- Fundamental
- Price
- CCEL $4.83
- TPCS $3.74
- Analyst Decision
- CCEL Strong Buy
- TPCS
- Analyst Count
- CCEL 1
- TPCS 0
- Target Price
- CCEL $8.50
- TPCS N/A
- AVG Volume (30 Days)
- CCEL 13.2K
- TPCS 27.3K
- Earning Date
- CCEL 07-22-2025
- TPCS 04-08-2025
- Dividend Yield
- CCEL 20.62%
- TPCS N/A
- EPS Growth
- CCEL N/A
- TPCS N/A
- EPS
- CCEL 0.01
- TPCS N/A
- Revenue
- CCEL $32,102,750.00
- TPCS $33,154,058.00
- Revenue This Year
- CCEL $2.49
- TPCS N/A
- Revenue Next Year
- CCEL $0.95
- TPCS N/A
- P/E Ratio
- CCEL $301.41
- TPCS N/A
- Revenue Growth
- CCEL 2.33
- TPCS 8.71
- 52 Week Low
- CCEL $4.75
- TPCS $2.05
- 52 Week High
- CCEL $9.43
- TPCS $4.42
- Technical
- Relative Strength Index (RSI)
- CCEL 40.85
- TPCS 54.79
- Support Level
- CCEL $4.80
- TPCS $3.45
- Resistance Level
- CCEL $6.35
- TPCS $3.85
- Average True Range (ATR)
- CCEL 0.26
- TPCS 0.23
- MACD
- CCEL -0.03
- TPCS 0.00
- Stochastic Oscillator
- CCEL 2.08
- TPCS 62.32
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
About TPCS TechPrecision Corporation Common stock
Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components.